Skip to main content
. 2021 Nov 24;12(11):1047–1063. doi: 10.5306/wjco.v12.i11.1047

Table 6.

Univariate analysis investigating the impact of neoadjuvant therapy radiochemotherapy on the response


OR
95%CI
P value
Radiological response
Disease progression Reference
Stable disease 4 0.39-40.42 0.240
Partial response 12.5 1.21-128.61 0.035
Complete response NA1
Pathological tumor response
0%-10% Reference
11%-30% 0.474 0.05-3.92 0.489
31%-50% 0.14 0.17-1.13 0.065
51%-70% 0.03 0.004-0.30 0.002
> 70% 0.01 0.001-0.16 0.001
Pathological nodal response
0%-10% Reference
11%-30% 0.474 0.057-3.92 0.489
31%-50% 0.14 0.17-0.13 0.065
51%-70% 0.03 0.004-0.30 0.002
> 70% 0.01 0.001-0.16 0.001
Downstaging
No Reference
Yes 8 2.34-27.32 0.001
1

Not applicable: only one patient in the chemoradiotherapy group and none in the Chemotherapy group. CI: Confidence interval.